Skip to main content

Emergent BioSolutions Inc.

EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001367644

No open-market purchases or sales by Emergent BioSolutions Inc. insiders were filed in the last 90 days; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Emergent BioSolutions Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of EBS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders1693183+17
Shares41.7M44.2K43.4M+1.76M (+4.2%)
Value$352.5M$392.7K$536.5M+$184.4M (+52.4%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (42)

Institutions that held Emergent BioSolutions Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to EBS in Q4 2025
InstitutionSharesValue% of portfolio
Jane Street Group, LLC395,457$4.89M0.01%
HRT Financial LP311,784$3.85M0.01%
Ancora Advisors, LLC170,469$2.11M0.04%
Coppell Advisory Solutions LLC161,307$1.96M0.20%
Credit Agricole S A125,000$1.54M0.00%
Ritholtz Wealth Management108,920$1.35M0.02%
James Investment Research Inc61,899$765.1K0.08%
Sierra Summit Advisors LLC48,460$599.0K0.09%
AdvisorShares Investments LLC39,900$493.2K0.08%
Weiss Asset Management LP37,785$467.0K0.01%
Raymond James Financial Inc28,281$349.6K0.00%
Aristeia Capital LLC27,949$345.4K0.01%
Schonfeld Strategic Advisors LLC22,910$283.2K0.00%
Skopos Labs, Inc.22,482$274.7K0.01%
Stirlingshire Investments, Inc.21,110$260.9K0.23%
Virtus ETF Advisers LLC19,500$241.0K0.11%
Wiley Bros.-Aintree Capital, LLC17,000$210.1K0.00%
Glenmede Trust Co NA16,234$200.7K0.00%
First Trust Advisors LP14,509$179.3K0.00%
Axq Capital, LP13,176$162.9K0.04%
Zacks Investment Management11,432$141.3K0.00%
Baron Wealth Management LLC10,785$133.3K0.04%
Vise Technologies, Inc.10,582$130.8K0.00%
Abel Hall, LLC10,439$129.0K0.03%
Kemnay Advisory Services Inc.8,660$107.0K0.02%
Great West Life Assurance Co3,645$45.0K0.00%
Torren Management, LLC2,995$37.0K0.02%
EFG International AG1,920$23.7K0.00%
Meeder Asset Management Inc1,581$19.5K0.00%
Triumph Capital Management700$8.65K0.00%
Nisa Investment Advisors, LLC500$6.18K0.00%
UBS Asset Management Americas Inc294$3.63K0.00%
Comerica Bank265$3.28K0.00%
Rockefeller Capital Management L.P.195$2.41K0.00%
Dogwood Wealth Management LLC188$2.32K0.00%
Northwestern Mutual Wealth Management Co78$9640.00%
Rothschild Investment LLC55$6800.00%
Optima Capital LLC55$6800.00%
MAI Capital Management53$6560.00%
SJS Investment Consulting Inc.16$1980.00%
SHP Wealth Management5$620.00%
Flagship Harbor Advisors, LLC2$250.00%

Sold out (25)

Institutions that held Emergent BioSolutions Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (3)

Institutions that held Emergent BioSolutions Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EBS in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Wolverine Trading, LLC23,370$208.9K
Glenmede Investment Management, LP20,798$183.4K
Lowe Wealth Advisors, LLC40$353